| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/12/2007 | CN101032471A Chuanhuning lipid freeze-dry powder agent and preparing method thereof |
| 09/12/2007 | CN101032470A Povidone-iodine bubble agent and preparing method |
| 09/12/2007 | CN101032469A Clindamycin phosphate bubble agent and preparing method |
| 09/12/2007 | CN101032468A Long-cycled lipid emulsion profofol preparation |
| 09/12/2007 | CN101032467A Superregulated long-cycled lipid emulsion carrying medicine reagent for mainline |
| 09/12/2007 | CN101032465A Dithranol stick |
| 09/12/2007 | CN101032464A Combination containing rimonabant and polyvinyl pyrrolidone, solid dispersion and the preparing and medicine application thereof |
| 09/12/2007 | CN101032452A Vitamine C phosphate magnesium microemulsion and preparing method thereof |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268214 peptidomimetics; enhanced uptake via gastrointestinal systems |
| 09/11/2007 | US7268210 PEG-LHRH analog conjugates |
| 09/11/2007 | US7268177 For the preparation of products for medical, dermatological or cosmetological purposes which come into contact with a wound, skin or mucous membranes |
| 09/11/2007 | US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | US7268110 Agents for preventing and treating thrombocytopenia |
| 09/11/2007 | US7267829 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 09/11/2007 | US7267822 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 09/11/2007 | US7267815 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | US7267718 Aqueous solutions are dip molded into hard capsules; veterinary medicine, drugs, foods, cosmetics, wrapping |
| 09/11/2007 | CA2432904C Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 09/11/2007 | CA2432900C Induced phase transition method for the production of microparticles containing hydrophilic active agents |
| 09/11/2007 | CA2388802C Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/11/2007 | CA2383355C Vitamin b solution with reduced bitterness |
| 09/11/2007 | CA2379314C Tablet for sucking, containing ambroxol |
| 09/11/2007 | CA2310536C Erythropoietin derivatives |
| 09/11/2007 | CA2298659C Fast-acting analgesic |
| 09/11/2007 | CA2275717C Chitosan-gelatin a microparticles |
| 09/11/2007 | CA2259520C Preparation for injection containing a lipid a analog and process for preparing the same |
| 09/11/2007 | CA2251281C Drug composition with controlled drug release rate |
| 09/11/2007 | CA2209770C Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds |
| 09/11/2007 | CA2200760C Aqueous compositions containing ciprofloxacine, and related use and process |
| 09/11/2007 | CA2132736C Topical and transdermal delivery system utilizing submicron oil spheres |
| 09/11/2007 | CA2124690C Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| 09/07/2007 | WO2007101202A1 Cell-targeted ikb and methods for the use thereof |
| 09/07/2007 | WO2007100776A2 Antimicrobial compositions and methods for locking catheters |
| 09/07/2007 | WO2007100755A1 Method for decreasing the toxic effects of nicotine on fetuses in pregnant women |
| 09/07/2007 | WO2007100385A2 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 09/07/2007 | WO2007099981A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | WO2007099966A1 Transdermal absorption preparation |
| 09/07/2007 | WO2007099661A1 Polymer micelle complex including nucleic acid |
| 09/07/2007 | WO2007099660A1 Polymer micelle complex including nucleic acid |
| 09/07/2007 | WO2007099650A1 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/07/2007 | WO2007098968A1 Triggered release of liposome contents |
| 09/07/2007 | WO2007098770A1 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 09/07/2007 | WO2007098755A1 A method for obtaining a microarray and an assay |
| 09/07/2007 | WO2007098612A1 Gastric acid resistant gelatin capsule composition and method for producing same |
| 09/07/2007 | WO2007098611A1 Compositions for treatment of cancer |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | WO2007083875A3 Biodegradable and thermosensitive poly(organophosphazene) hydrogel, preparation method thereof and use thereof |
| 09/07/2007 | WO2007071733A3 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 09/07/2007 | WO2007056153A3 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 09/07/2007 | WO2007051785A3 Use of sdf-1 for the treatment and/or prevention of neurological diseases |
| 09/07/2007 | WO2007044976A3 Improved testosterone gel and method of use |
| 09/07/2007 | WO2007022494A3 Multi-drug ligand conjugates |
| 09/07/2007 | WO2006131721A3 Topical ungual formulations |
| 09/07/2007 | WO2006122309B1 Stable lyophilized anthracycline glycosides |
| 09/07/2007 | WO2006110476A3 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates |
| 09/07/2007 | WO2006102965A9 Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
| 09/07/2007 | CA2656693A1 Method for making polyethylene glycol carbonates |
| 09/07/2007 | CA2650113A1 Ankyrin-like motif-based peptides for the treatment of cancer |
| 09/07/2007 | CA2644552A1 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/07/2007 | CA2643714A1 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 09/07/2007 | CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | CA2643569A1 Method of treating periodontitis and of reducing dentinal sensitivity |
| 09/07/2007 | CA2643145A1 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 09/07/2007 | CA2641160A1 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| 09/07/2007 | CA2638797A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | CA2633464A1 Compositions and methods for dermal delivery of drugs |
| 09/07/2007 | CA2628964A1 Formulations of fispemifene |
| 09/07/2007 | CA2611577A1 Antibiotic kit and composition and uses thereof |
| 09/06/2007 | US20070208134 Anti-scarring drug combinations and use thereof |
| 09/06/2007 | US20070208088 Pqs: a new hydrotrope for solubilizing lipophilic compounds in water |
| 09/06/2007 | US20070208060 Compounds for treating inflammatory diseases |
| 09/06/2007 | US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions |
| 09/06/2007 | US20070207956 Stabilised solid compositions of factor VII polypeptides |
| 09/06/2007 | US20070207484 Polyol-modified silanes as precursors for silica |
| 09/06/2007 | US20070207215 Medicament On The Basis Of Honey, Preparation And Use Thereof |
| 09/06/2007 | US20070207214 Oral pharmaceutical compositions with controlled release and prolonged absorption |
| 09/06/2007 | US20070207196 Tocopherol-modified therapeutic drug compound formulations |
| 09/06/2007 | US20070207146 Therapeutic using a bispecific antibody |
| 09/06/2007 | US20070207138 S/O Type Pharmaceutical Preparation and Method for Producing the Same |
| 09/06/2007 | US20070207133 Emulsifier Composition for Shortening |
| 09/06/2007 | US20070206081 Ejection liquid and ejection method |
| 09/05/2007 | EP1829880A2 Derivatives of camptothecin for use in treating cancer |
| 09/05/2007 | EP1829856A2 Transfection reagents |
| 09/05/2007 | EP1829555A2 Method of enhancing delivery of a therapeutic nucleic acid |
| 09/05/2007 | EP1829554A2 Site specific protein modification by mutagenesis |
| 09/05/2007 | EP1829549A1 Amorphous composition |
| 09/05/2007 | EP1829546A1 Formulations containing tetracyclines for treating or preventing mucositis |
| 09/05/2007 | EP1829533A2 Pharmaceutical formulations for dry powder inhalers |
| 09/05/2007 | EP1829529A1 Controlled release compositions of estradiol metabolites |
| 09/05/2007 | EP1829528A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 09/05/2007 | EP1829527A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 09/05/2007 | EP1829526A1 Liposome and method of injecting substance into cell by using the same |
| 09/05/2007 | EP1828219A1 Sirna silencing of apolipoprotein b |
| 09/05/2007 | EP1827501A2 Stabilized polymeric thiol reagents |
| 09/05/2007 | EP1827500A2 Pegylated liposomal doxorubicin in combination with ecteinescidin 743 |
| 09/05/2007 | EP1827499A1 Compositions comprising azelastine and methods of use thereof |
| 09/05/2007 | EP1827498A2 Stabilisation of glucocorticoid esters with acids |